Healthy volunteers needed to test new fatty liver drug
NCT ID NCT07099118
First seen Apr 29, 2026 · Last updated May 16, 2026 · Updated 1 time
Summary
This early-stage study tests a new medicine called HEC169584 in 96 healthy adults aged 18 to 45. The goal is to check if the drug is safe and how the body processes it. This is a first step before testing it in people with non-alcoholic steatohepatitis (NASH), a type of fatty liver disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC STEATOHEPATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
No. 49, Huayuan North Road, Haidian District, Beijing Municipality
RECRUITINGBeijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.